Seronegative Lambert-Eaton myasthenic syndrome: study of 110 Japanese patients
- PMID: 12473768
- DOI: 10.1212/01.wnl.0000037485.56217.5f
Seronegative Lambert-Eaton myasthenic syndrome: study of 110 Japanese patients
Abstract
The authors characterized the clinical and immunologic features of 110 patients with Lambert-Eaton myasthenic syndrome (LEMS). Anti-P/Q-type voltage-gated calcium channels (VGCC) antibodies were detected in 85% of the patients (seropositive) but not in the rest (seronegative). Except for the indication that small cell lung carcinoma is less common in seronegative patients, no significant differences were found in the clinical characteristics of patients who had or did not have anti-P/Q-type VGCC antibodies. The results of passive transfer experiments suggest that seronegative LEMS is also an autoantibody-mediated disorder.
Comment in
-
What's in the serum of seronegative MG and LEMS?: MuSK et al.Neurology. 2002 Dec 10;59(11):1672-3. doi: 10.1212/01.wnl.0000041026.90947.79. Neurology. 2002. PMID: 12473750 No abstract available.
-
What's in the serum of seronegative MG and LEMS?Neurology. 2003 Jul 22;61(2):277; author reply 277-8. doi: 10.1212/wnl.61.2.277-a. Neurology. 2003. PMID: 12874426 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources